Mrudula Donepudi is clinical development and medical affairs professional with over 12 years of biotech and pharmaceutical industry experience in the Boston/Cambridge biotech hub. During her career, she’s been part of teams that have brought drugs successfully through regulatory approval and launch in the market in oncology and liver disease. Her experience spans clinical research and operations, and she has led medical writing and scientific communications teams. Mrudula joined Editas Medicine, Inc. in January 2018 and is currently Director of Clinical Science and Scientific Communications. She completed a post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and was awarded as a PhD in Biochemistry from the University of Zurich, Switzerland.